Development and evaluation of injection-molded sustained-release tablets containing ethylcellulose and polyethylene oxide

Drug Development and Industrial Pharmacy

Volumn 37, Issue 2, 2011, Pages 149-159

  Quinten, T ^a   De Beer, T ^a   Almeida, A ^a   Vlassenbroeck, J ^a   Van Hoorebeke, L ^a   Remon, J P ^a   Vervaet, C ^a  

^a GHENT UNIVERSITY   (Belgium)

Author keywords

Ethylcellulose; injection molding; matrix tablet; melt extrusion; metoprolol tartrate; polyethylene oxide; solid dispersion; sustained release; viscosity grade

Indexed keywords

ETHYL CELLULOSE; MACROGOL; METOPROLOL TARTRATE; SEBACIC ACID DIBUTYL ESTER;

ARTICLE; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DISPERSION; DRUG FORMULATION; DRUG MIXTURE; DRUG RELEASE; IN VITRO STUDY; MATRIX TABLET; MOLECULAR WEIGHT; POROSITY; SUSTAINED RELEASE PREPARATION; TEMPERATURE; THERMOGRAPHY; TOMOGRAPHY; VISCOSITY; X RAY DIFFRACTION; X RAY TOMOGRAPHY;

CALORIMETRY, DIFFERENTIAL SCANNING; CELLULOSE; DELAYED-ACTION PREPARATIONS; DICARBOXYLIC ACIDS; EXCIPIENTS; METOPROLOL; POLYETHYLENE GLYCOLS; TABLETS; TEMPERATURE; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TRANSITION TEMPERATURE; VISCOSITY; X-RAY DIFFRACTION;

EID: 79952939074     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.3109/03639045.2010.498426     Document Type: Article

References (22)

1. Breitenbach J. (2002). Melt extrusion: From process to drug delivery technology. Eur J Pharm Biopharm, 54(2):107-17. (Pubitemid 34919382)
2. Verhoeven E, Vervaet C, Remon JP. (2006). Xanthan gum to tailor drug release of sustained-release ethylcellulose minimatrices prepared via hot-melt extrusion: In vitro and in vivo evaluation. Eur J Pharm Biopharm, 63(3):320-30. (Pubitemid 43776225)
3. Young CR, Crowley MM, Dietzsch C, McGinity JW. (2007). Physicochemical properties of film-coated melt-extruded pellets. J Microencapsul, 24(1):57-71. (Pubitemid 46957684)
4. Rothen-Weinhold A, Besseghir K, Vuaridel E, Sublet E, Oudry N, Kubel F, et al. (1999). Injection-molding versus extrusion as manufacturing technique for the preparation of biodegradable implants. Eur J Pharm Biopharm, 48(2):113-21. (Pubitemid 29401987)
5. Crowley MM, Fredersdorf A, Schroeder B, Kucera S, Prodduturi S, Repka MA, et al. (2004). The influence of guaifenesin and ketoprofen on the properties of hot-melt extruded polyethylene oxide films. Eur J Pharm Sci, 22(5):409-18. (Pubitemid 38953899)
6. Repka MA, Gutta K, Prodduturi S, Munjal M, Stodghill SP. (2005). Characterization of cellulosic hot-melt extruded films containing lidocaine. Eur J Pharm Biopharm, 59(1):189-96. (Pubitemid 39573452)
7. Crowley MM, Zhang F, Repka MA, Thumma S, Upadhye SB, Battu SK, et al. (2007). Pharmaceutical applications of hot-melt extrusion: Part 1. Drug Dev Ind Pharm, 33:909-26. (Pubitemid 47463803)
8. De Brabander C, Vervaet C, Remon JP. (2003). Development and evaluation of sustained release mini-matrices prepared via hot melt extrusion. J Control Release, 89(2):235-47. (Pubitemid 36507018)
9. Crowley MM, Schroeder B, Fredersdorf A, Obara S, Talarico M, Kucera S, et al. (2004). Physicochemical properties and mechanism of drug release from ethyl cellulose matrix tablets prepared by direct compression and hot-melt extrusion. Int J Pharm, 269(2):509-22. (Pubitemid 38045312)
10. Follonier N, Doelker E, Cole ET. (1994). Evaluation of hot-melt extrusion as a new technique for the production of polymer based pellets for sustained release capsules containing high loadings of freely soluble drugs. Drug Dev Ind Pharm, 20(8):1323-39. (Pubitemid 24201240)
11. Quinten T, De Beer T, Vervaet C, Remon JP. (2009). Evaluation of injection moulding as a pharmaceutical technology to produce matrix tablets. Eur J Pharm Biopharm, 71(1):145-54.
12. Quinten T, Gonissen Y, Cnudde V, Masschaele B, Van Hoorebeke L, Remon JP, et al. (2009). Development of injection moulded matrix tablets based on mixtures of ethylcellulose and low-substituted hydroxypropylcellulose. Eur J Pharm Sci, 37(3-4):207-16.
13. Zhang F, McGinity JW. (1999). Properties of sustained-release tablets prepared by hot-melt extrusion. Pharm Dev Technol, 4(2):241-50. (Pubitemid 29211025)
14. Ritger PL, Peppas NA. (1987). A simple equation for description of solute release II. Fickian and anomalous release from swellable devices. J Control Release, 5(1):37-42. (Pubitemid 17106644)
15. Crowley MM, Zhang F, Koleng J, McGinity JW. (2002). Stability of polyethylene oxide in matrix tablets prepared by hot-melt extrusion. Biomaterials, 23(21):4241-8. (Pubitemid 34814993)
16. Zhang YE, Tchao R, Schwartz JB. (2001). Effect of processing methods and heat treatment on the formation of wax matrix tablets for sustained drug release. Pharm Dev Technol, 6(2):131-44. (Pubitemid 32532018)
17. Bettini R, Catellani PL, Santi P, Massimo G, Peppas NA, Colombo P. (2001). Translocation of drug particles in HPMC matrix gel layer: Effect of drug solubility and influence on release rate. J Control Release, 70(3):383-91. (Pubitemid 32155461)
18. Prodduturi S, Manek RV, Kolling WM, Stodghill SP, Repka MA. (2005). Solid-state stability and characterization of hot-melt extruded poly(ethylene oxide) films. J Pharm Sci, 94(10):2232-45. (Pubitemid 41665283)
19. Apicella A, Cappello C, Delnobile MA, Larotonda MI, Mensitieri G, Nicolais L. (1993). Poly(ethylene oxide) PEO and different molecular-weight PEO blends monolithic devices for drug release. Biomaterials, 14(2):83-90. (Pubitemid 23072680)
20. Maggi L, Segale L, Torre ML, Ochoa E, Conte U. (2002). Dissolution behaviour of hydrophilic matrix tablets containing two different polyethylene oxides (PEOs) for the controlled release of water-soluble drug. Dimensionality study. Biomaterials, 23(4):1113-9. (Pubitemid 33109042)
21. Mishra RK, Dubey KS. (2000). Analysis of thermodynamic parameters of glass forming polymeric melts. J Therm Anal Calorim, 62(3):687-702. (Pubitemid 32135775)
22. Forster A, Hempenstall J, Tucker I, Rades T. (2001). Selection of excipients for melt extrusion with two poorly water-soluble drugs by solubility parameter calculation and thermal analysis. Int J Pharm, 226(1-2):147-61. (Pubitemid 32800790)